Cuijie Shao
Binzhou, 256603, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
AJUBA: The Master Regulator Bridging EMT and Immune Evasion in Colorectal Cancer.
Journal: Mediators of inflammation
Published: November 21, 2025
Fluorescence and magnetic resonance imaging of ONL-93 cells in a rat model of ischemic.
Journal: Magnetic resonance imaging
Published: March 16, 2023
The "Hand as Foot" teaching method in variants of the brain Willis circle anatomy.
Journal: Asian journal of surgery
Published: August 04, 2022
The "Hand as Foot" teaching method in liver segment anatomy.
Journal: Asian journal of surgery
Published: July 21, 2022
Vibrio vulnificus necrotizing fasciitis with sepsis presenting with pain in the lower legs in winter: a case report.
Journal: BMC infectious diseases
Published: January 08, 2022
Retraction notice to 'The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC' [EBioMedicine 37 (2018) 188-204].
Journal: EBioMedicine
Published: January 25, 2021
UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells.
Journal: Journal of oncology
Published: July 05, 2018
Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway.
Journal: Oncology reports
Published: December 05, 2017
[Retracted] Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway.
Journal: Oncology reports
Published: December 05, 2017
Last Updated: 09/26/2026